Choose the experimental features you want to try

This document is an excerpt from the EUR-Lex website

Document 52026XC00736

Summary of European Commission Decisions on authorisations for the placing on the market for the use and/or for use of substances listed in Annex XIV to Regulation (EC) No 1907/2006 of the European Parliament and of the Council concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) (Published pursuant to Article 64(9) of Regulation (EC) No 1907/2006)

C/2026/595

OJ C, C/2026/736, 11.2.2026, ELI: http://data.europa.eu/eli/C/2026/736/oj (BG, ES, CS, DA, DE, ET, EL, EN, FR, GA, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

ELI: http://data.europa.eu/eli/C/2026/736/oj

European flag

Official Journal
of the European Union

EN

C series


C/2026/736

11.2.2026

Summary of European Commission Decisions on authorisations for the placing on the market for the use and/or for use of substances listed in Annex XIV to Regulation (EC) No 1907/2006 of the European Parliament and of the Council concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH)

(Published pursuant to Article 64(9) of Regulation (EC) No 1907/2006  (1) )

(Text with EEA relevance)

(C/2026/736)

Decision granting an authorisation

Reference of the decision (2)

Date of decision

Substance name

Holder of the authorisation

Authorisation number

Authorised use

Date of expiry of review period

Reasons for the decision

C(2026) 595

4 February 2026

bis(2-ethylhexyl) phthalate (DEHP) (EC No 204-211-0; CAS No117-81-7)

Baxter S.A., Boulevard René Branquart 80, 7860 Lessines, Belgium

REACH/26/2/0

Formulation of bis(2-ethylhexyl) phthalate (DEHP) mixtures for application in immediate packaging of medicines and medical device

14 December 2031

In accordance with Article 60(4) of Regulation (EC) No 1907/2006, the socio-economic benefits outweigh the risk to human health and the environment from the use of the substance and there are no suitable alternative substances or technologies.

Vantive Manufacturing Limited, Moneen Road, Mayo, F23 XR63 Castlebar, Ireland

REACH/26/2/1

 

Baxter (Malta) Trading Co Ltd, A47 Marsa Industrial estate, MRS3000 Marsa, Malta

REACH/26/2/2

 

Gambro Dasco SpA., Via Modenese 66, 41036 Medolla, Emilia-Romagna Italy

REACH/26/2/3

 

Baxter S.A., Boulevard René Branquart 80, 7860 Lessines, Belgium

REACH/26/2/4

Use of bis(2-ethylhexyl) phthalate (DEHP)-containing plastics for immediate packaging of medicinal products

 

Vantive Manufacturing Limited, Moneen Road, Mayo, F23 XR63 Castlebar, Ireland

REACH/26/2/5

 

Baxter (Malta) Trading Co Ltd, A47 Marsa Industrial estate, MRS3000 Marsa, Malta

REACH/26/2/6

 

Gambro Dasco SpA., Via Modenese 66, 41036 Medolla, Emilia-Romagna Italy

REACH/26/2/7

 

Baxter S.A., Boulevard René Branquart 80, 7860 Lessines, Belgium

REACH/26/2/8

Use of bis(2-ethylhexyl) phthalate (DEHP)-based mixtures as a lubricating/sealing agent for the insertion of port closures into empty bags and assembly/connection of parts, that are used in immediate packaging of medicines

14 December 2028

Vantive Manufacturing Limited, Moneen Road, Mayo, F23 XR63 Castlebar, Ireland

REACH/26/2/9

 

Baxter (Malta) Trading Co Ltd, A47 Marsa Industrial estate, MRS3000 Marsa, Malta

REACH/26/2/10

 

Gambro Dasco SpA., Via Modenese 66, 41036 Medolla, Emilia-Romagna Italy

REACH/26/2/11

 


(1)   OJ L 396, 30.12.2006, p. 1.

(2)  The decision is available on the European Commission website at: Authorisation (europa.eu)


ELI: http://data.europa.eu/eli/C/2026/736/oj

ISSN 1977-091X (electronic edition)


Top